跳至主要内容
临床试验/ISRCTN10644347
ISRCTN10644347已完成未知

A single arm observational SYmptom Study of radioThErapy in MeSothelioma

HS Greater Glasgow and Clyde (UK)0 个研究点目标入组 40 人开始时间: 2012年8月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25654216 results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27117437 results

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. >/=18 years of age.
  • 2. Histological or multi-disciplinary team (MDT) diagnosis of mesothelioma
  • 3. Able to complete study assessments
  • 3. Life expectancy of at least 3 months based on clinical judgement
  • 4. Due to receive radiotherapy for pain resulting from mesothelioma (defined as index site ? site of radiotherapy)
  • 5. Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2
  • 6. CT scan within 6 weeks of radiotherapy
  • 7. Worst pain >4/10 (0-10 Visual Analogue Scale) corresponding to the index site

排除标准

  • 1. Received chemotherapy or radiotherapy in the preceding six weeks that is likely to alter pain at the index site during the duration of the study
  • 2. Planned chemotherapy during the period of the study that is likely to alter pain during the course of the study
  • 3. Psychotic disorders or cognitive impairment
  • 4. Co-existing lung tumours at the time of study entry
  • 5. Pregnant or breastfeeding

研究者

发起方
HS Greater Glasgow and Clyde (UK)

相似试验